Vaxart Announces Oral Presentation of Clinical Data from Oral Influenza Vaccine Program at the World Vaccine Congress
Monday, April 2nd 2018 at 8:10pm UTC SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Vaxart, Inc. (NA
Vaxart Announces Oral Presentation of Clinical Data from Oral Influenza Vaccine Program at the World Vaccine Congress
Source: Virology News